U.S., May 13 -- ClinicalTrials.gov registry received information related to the study (NCT07579689) titled 'Effects of Ginkgo Biloba on Blood Biomarkers in Mild Cognitive Impairment' on May 05.
Brief Summary: This study evaluates the effects of Ginkgo biloba on blood biomarkers related to Alzheimer's disease in patients with mild cognitive impairment. Participants will be randomly assigned to receive either Ginkgo biloba or a placebo for 6 months. Changes in blood biomarkers, including p-tau217 and neurofilament light (NfL), as well as cognitive function, will be assessed to determine whether Ginkgo biloba may influence disease-related biological processes.
Study Start Date: June, 2026
Study Type: INTERVENTIONAL
Condition:
Mild Cogniti...